TC Home

The only technical publication dedicated to readers who formulate, manufacture, or package solid dosage forms.

Posted October 17, 2018

EAST RUTHERFORD, NJ—Cambrex, a manufacturer of small molecules and generic APIs, has acquired CDMO Halo Pharma, Whippany, NJ. Halo is currently engaged in more than 100 product development projects for over 70 customers. The CDMO’s 450 employees will join Cambrex’s 1,200 employees across the US and Europe.

Posted October 17, 2018

ROCKVILLE, MD–USP established the Impurities for Development (IfD) program to help pharmaceutical manufacturers meet quality standards and regulatory requirements to control impurities that may be harmful to end-users.